Endoscopic treatment of vesicoureteral reflux in pediatric patients
Endoscopic treatment is a minimally invasive treatment for managing patients with vesicoureteral reflux (VUR). Although several bulking agents have been used for endoscopic treatment, dextranomer/hyaluronic acid is the only bulking agent currently approved by the U.S. Food and Drug Administration fo...
Main Authors: | Jong Wook Kim, Mi Mi Oh |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Pediatric Society
2013-04-01
|
Series: | Korean Journal of Pediatrics |
Subjects: | |
Online Access: | http://kjp.or.kr/upload/pdf/kjped-56-145.pdf |
Similar Items
-
The learning curve of sting method for endoscopic injection treatment of vesicoureteral reflux
by: Ayhan Dalkiliç, et al. -
New bulking agent for the treatment of vesicoureteral reflux: Polymethylmethacrylate/dextranomer
by: Sang Woon Kim, et al.
Published: (2018-05-01) -
Changing bulking agent may require change in injection volume for endoscopic treatment of vesicoureteral reflux
by: Ali Tekin, et al. -
Impact of de novo vesicoureteral reflux on transurethral surgery outcomes in pediatric patients with ureteroceles
by: Sang Hoon Song, et al.
Published: (2019-07-01) -
Ureteral Triplication and Contralateral Duplication with Vesicoureteral Reflux
by: Haluk Söylemez, et al.
Published: (2011-11-01)